top of page
Search Results

309 items found for "Molecular biology"

  • 📰 GPCR Weekly News, April 17 to 23, 2023

    Structural and Molecular Insights into GPCR Function Lysophosphatidic acid, a simple phospholipid with (June 4 - 8, 2023). 2023 Molecular Pharmacology (GRS) Seminar GRC. (June 10 - 11, 2023). Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

  • 📰 GPCR Weekly News, March 27 to April 4, 2023

    Structural and Molecular Insights into GPCR Function Predicted Three-Dimensional Structure of the GCR1 December 2022 Addex Raises $5.0 Million in Equity Financing Testing the limits of SMILES-based de novo molecular - leadXpro and InterAx part of Fujitsu CaaS GPCR Events, Meetings, and Webinars SLAS 2023 Building Biology (June 4 - 8, 2023). 2023 Molecular Pharmacology (GRS) Seminar GRC. (June 10 - 11, 2023). Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

  • Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR

    This paper thoroughly investigated the role of single amino acid changes to clarify the molecular mechanisms By pinpointing the molecular determinants of ligand efficacy and potency in GPCR signalling, this research Molecular determinants of ligand efficacy and potency in GPCR signaling. Molecular basis of proton-sensing by G protein-coupled receptors. bioRxiv .

  • N-Acyl Amides from Neisseria meningitidis and Their Role in Sphingosine Receptor Signaling

    The molecular mechanisms N. meningitidis employ to manipulate the immune system, translocate the mucosal Human-associated bacteria encode a variety of bioactive small molecules with growing evidence for N-acyl amides as being important signaling molecules.

  • 📰 GPCR Weekly News, September 25 to October 1, 2023

    2024 | SLAS2024 International Conference and Exhibition March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 5 - 10 2024 | Chemotactic Cytokines GPCR Jobs NEW In vivo Antibody Discovery Research Scientist NEW In Vitro Biologist /Molecular Pharmacologist Senior Vice President, Oncology Clinical Research Scientist (level I or II)

  • 📰 GPCR Weekly News, March 25 to March 31, 2024

    Our next symposium on Structural and Molecular Insights into GPCR Function is scheduled for June 7th. 2024 GPCR Activation and Signaling PACAP key interactions with PAC1, VPAC1, and VPAC2 identified by molecular Phosphorylation and G-Protein Mediated Signaling Networks June 25 - 29, 2024 | FENS Forum 2024 October 2024 | Biologics physiology, optical imaging, substance use disorder, pharmacology Research Fellow Postdoctoral Fellow – Molecular Pharmacology of Feeding Behavior Director of Laboratory Operations - Single-molecule Imaging Center

  • Nanobodies: New Dimensions in GPCR Signaling Research

    Nbs are useful tools for dynamic biological systems; they have been used to crystallize flexible membrane proteins, transient multiprotein assemblies, and individual molecules of complex proteins. Combinatorial biology methods such as phage display, yeast display, and ribosome display can be used International journal of molecular sciences, 24(6), 5994. https://doi.org/10.3390/ijms24065994 Manglik Structural biology.

  • Therapeutic validation of an orphan G protein‐coupled receptor

    is of great importance in order to better understanding human physiology as well as to dissect the molecular In this study Marsango et al. address two key questions in GPR84 biology and pharmacology: 1. how GPR84 and 2. which ligands can be used as tool compounds to study the function and biology of this receptor agonist ligands (Pillaiyar et al., 2018) with biased properties which can help to better elucidate the molecular

  • 📰 GPCR Weekly News, May 29 to June 4, 2023

    GPCR Symposium is coming up on July 21st on Structural and Molecular Insights on GPCR Activation. We look forward to seeing you in a few days at the Molecular Pharmacology GRC and the associated Molecular Molecular mechanism of fatty acid activation of FFAR1. Molecular insights into peptide agonist engagement with the PTH receptor. Targeting biased signaling by PAR1: function and molecular mechanism of parmodulins.

  • Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes

    different ligands acting on the same receptor trigger distinct signaling pathways, leading to varied biological The molecular mechanisms underlying biased agonism at the GLP-1R are beginning to be elucidated through As our understanding of the molecular basis of biased agonism continues to grow, it is likely to play Wootten, D., et al., The Extracellular Surface of the GLP-1 Receptor Is a Molecular Trigger for Biased

  • Precise druggability of the PTH type 1 receptor

    Class B G protein-coupled receptors (GPCRs) are notoriously difficult to target by small molecules because deep within the transmembrane domain limits the identification and development of nonpeptide small molecule parathyroid hormone type 1 receptor (PTHR) as a prototypic class B GPCR target, and a combination of molecular collective dynamics of the receptor and used this ensemble of PTHR conformers to identify selective small molecules allosteric modulators of PTHR signaling that could be extended to GPCRs to expedite discoveries of small molecules

  • 📰 GPCR Weekly News, July 3 to 9, 2023

    GPCR Symposium on Structural and Molecular Insights on GPCR Activation is quickly approaching! Structural and Molecular Insights into GPCR Function Dual mechanisms of cholesterol-GPCR interactions Molecular Dynamics and Machine Learning Study of Adrenaline Dynamics in the Binding Pocket of GPCR. Postdoctoral Fellow, Caron Lab NEW Clinical Trial Associate Research Scientist/Senior Scientist I - Molecular

  • Activation of GPR183 by 7 α,25-Dihydroxycholesterol Induces Behavioral Hypersensitivity through...

    These effects are blocked by the selective small molecule GPR183 antagonist, SAE-14. However, the molecular mechanisms engaged downstream of GPR183 in the spinal cord are not known. SIGNIFICANCE STATEMENT: Using a multi-disciplinary approach, we have characterized the molecular mechanisms

  • 📰 GPCR Weekly News, May 20 to 26, 2024

    support this exciting event that unites scientists worldwide to explore all aspects of adhesion GPCR biology receptor dimer: Classification, future prospects, and pathophysiological perspectives Structural and Molecular Phosphorylation and G-Protein Mediated Signaling Networks June 25 - 29, 2024 | FENS Forum 2024 October 2024 | Biologics Senior Research Associate/Associate Scientist, Protein Science Post-Doctoral Fellow—Pharmacology/Cell Biology

  • An overview of the compartmentalized GPCR Signaling: Relevance and Implications

    Another challenge is the potential interference of tagging molecules with GPCR function. The Journal of membrane biology, 254(3), 259–271. https://doi.org/10.1007/s00232-020-00158-7 Gonçalves-Monteiro Towards a molecular understanding of endosomal trafficking by Retromer and Retriever. Nature chemical biology, 5(10), 734–742. https://doi.org/10.1038/nchembio.206 Wei, H., Ahn, S., Shenoy Nature chemical biology, 13(7), 799–806. https://doi.org/10.1038/nchembio.2389 Godbole, A., Lyga, S.,

  • 📰 GPCR Weekly News, July 10 to 16, 2023

    GPCR Symposium on Structural and Molecular Insights on GPCR Activation! Structural and Molecular Insights into GPCR Function ALX/FPR2 Activation by Stereoisomers of D1 Resolvins Elucidating with Molecular Dynamics Simulation. GPCR) Postdoctoral Fellow, Caron Lab Clinical Trial Associate Research Scientist/Senior Scientist I - Molecular

  • The NPXXY Motif Regulates β-Arrestin Recruitment by the CB1 Cannabinoid Receptor

    Background: Activation of signaling effectors by G-protein coupled receptors (GPCRs) depends on different molecular different conformational changes in response to biased ligands and could therefore participate in a molecular

  • 📰 GPCR Weekly News, April 22 to 28, 2024

    GPCR Symposia Join us on June 7th for our symposium on Structural and Molecular Insights into GPCR Function fungus Arthrobotrys oligospora detects prey pheromones via G protein-coupled receptors Structural and Molecular Insights into GPCR Function Fungal alkaloid malbrancheamide reorients the lipid binding domain of GRK5 Molecular June 25 - 29, 2024 | FENS Forum 2024 NEW July 8 - 10, 2024 | 4th IRN i-GPCRnet Annual October 2024 | Biologics

  • Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5

    In this work, molecular docking screens for allosteric modulators targeting the metabotropic glutamate Chemical libraries containing fragment- (1.6 million molecules) and lead-like (4.6 million molecules)

  • Structural dynamics of Smoothened (SMO) in ciliary membrane and its interaction with membrane lipids

    We have carried out MARTINI coarse-grained molecular dynamics simulations of SMO in POPC and in ciliary membrane models, respectively, to study the interactions of SMO with cholesterol and other lipid molecules in the ciliary membrane, and to gain molecular-level insights into the role of the primary cilia in

  • Harnessing Deep Mutational Scanning for Enhanced Drug Discovery

    resulting phenotype, researchers can identify essential domains and residues crucial for the protein's biological Lead Optimisation Once potential lead compounds are identified, DMS can be employed to refine these molecules Another promising development is the application of DMS to a wider array of biological systems, including Molecular basis of proton-sensing by G protein-coupled receptors. Molecules , 25 (9), 2265. https://doi.org/10.3390/molecules25092265

  • Fluorescent Ligands Targeting Intracellular Allosteric Binding Site of the Chemokine Receptor CCR2

    August 2022 "Fluorescently labeled ligands are versatile molecular tools to study G protein-coupled receptors Thus, our small-molecule-based fluorescent CCR2 ligand 14 represents a promising tool for future studies

  • Artificial intelligence – faster, smarter, cheaper GPCR drug discovery

    and development of novel drugs, optimize drug design processes, and enhance the understanding of GPCR biology the input, including amino acid sequences or structural data (from X-ray crystallography, cryoEM or molecular interactions: ML can predict GPCR-ligand interactions based on input data of protein sequences and molecular Virtual screening: molecular docking and virtual screening can efficiently analyze large databases of De novo drug design: AI algorithms can generate new molecules with desired properties, such as binding

  • Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5

    In this work, molecular docking screens for allosteric modulators targeting the metabotropic glutamate Chemical libraries containing fragment- (1.6 million molecules) and lead-like (4.6 million molecules)

  • The Adhesion GPCR VLGR1/ADGRV1 Regulates the Ca2+ Homeostasis at Mitochondria-Associated ER Membrane

    Affinity proteomics revealed that in the interactome of VLGR1, molecules are enriched that are associated Our data demonstrate the molecular and functional interaction of VLGR1 with components in MAMs and point

  • Discovery of 3(2-aminoethyl)-thiazolidine-2,4-diones as a novel chemotype of sigma-1 receptor ligand

    It is classified into two types: Sigma-1 (S1R) and Sigma-2 (S2R) based on their biological functions. In addition, molecular docking predicted that all the compounds showed the critical salt bridge with

  • Lysine 101 in the CRAC Motif in Transmembrane Helix 2 Confers Cholesterol-Induced Thermal...

    In the present work, we explored the molecular basis of cholesterol-induced thermal stability of the We envision that our results could have potential implications in structural biological advancements

  • Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies

    , metastasis, and drug resistance and inflammation, all of which are influenced by the cellular and molecular few more have demonstrated clear improvement when administered in combination with other therapeutic molecules

bottom of page